GGenetics Read More Researchers pinpoint PRMT5 as a promising target for cancer drugsJuly 26, 2025 A potential target for experimental drugs that block PRMT5 – a naturally occurring enzyme some tumors rely more…
GGenetics Read More Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007’s Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA’s Annual Scientific SessionsJune 21, 2025 Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight…